Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2726-2732
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2726
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2726
Refs | Combination regimens | Dose | Treatment duration | Eradication rate (ITT) | P | |
PUD | NUD | |||||
N/T.N (%) | N/T.N (%) | |||||
23 | Pan/Met/Cla | 40 mg q.d./400 mg b.i.d./250 mg b.i.d. | 7 d | 54/65 (83.1) | 21/24 (87.5) | 0.613 |
23 | Pan/Met/Cla | 40 mg b.i.d./400 mg b.i.d./250 mg b.i.d. | 7 d | 54/64 (84.4) | 18/22 (81.8) | 0.781 |
24 | Ome/Met/Cla | 40 mg q.d./500 mg b.i.d./250 mg b.i.d. | 7 d | 15/19 (78.95) | 5/6 (83.3) | 0.819 |
25 | Pan/Met/Amo | 40 mg b.i.d./500 mg b.i.d./1 g b.i.d. | 7 d | 14/19 (73.7) | 7/11 (63.6) | 0.569 |
26 | Ome/Met/Amo | 40 mg q.d./400 mg t.i.d.1/750 mg b.i.d. | 14 d | 22/27 (81.5) | 22/37 (59.5) | 0.063 |
-
Citation: Huang JQ, Zheng GF, Hunt RH, Wong WM, Lam SK, Karlberg J, Wong BCY. Do patients with non-ulcer dyspepsia respond differently to
Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. World J Gastroenterol 2005; 11(18): 2726-2732 - URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2726.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i18.2726